825 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Downtrend
Article Searches
Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc. https://www.fool.com/investing/2017/06/27/better-buy-eli-lilly-and-company-vs-merck.aspx?source=iedfolrf0000001 Jun 27, 2017 - Find out which of these pharmaceutical stocks is the best pick right now.
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020? https://www.fool.com/investing/2017/09/16/which-of-these-5-will-be-the-best-selling-drug-wor.aspx?source=iedfolrf0000001 Sep 16, 2017 - All five of these drugs have a genuine shot at $10 billion or more in annual sales in 2020.
3 Top Animal-Health Companies to Buy in 2017 https://www.fool.com/investing/2017/05/21/3-top-animal-health-companies-to-buy-in-2017.aspx?source=iedfolrf0000001 May 21, 2017 - Looking for top animal-health companies to buy? Check out Zoetis, Merck, and Lilly.
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher? https://www.fool.com/investing/2017/09/09/3-biotech-stocks-that-skyrocketed-this-week-can-th.aspx?source=iedfolrf0000001 Sep 09, 2017 - Insmed, Newlink Genetics, and Voyager Therapeutics stocks soar on positive news.
Early Movers: KBH, MRK, MA, V, AIG, AMZN, VLKAY & more https://www.cnbc.com/2017/09/29/early-movers-kbh-mrk-ma-v-aig-amzn-vlkay-more.html Sep 29, 2017 - Names on the move ahead of the open.
Pharma Industry Outlook - February/March 2017 http://www.zacks.com/commentary/104804/pharma-industry-outlook-february-march-2017?cid=CS-ZC--104804 Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
An Unprecedented FDA Approval Bodes Well for this Drug Stock https://www.fool.com/investing/2017/06/06/an-unprecedented-fda-approval-bodes-well-for-share.aspx?source=iedfolrf0000001 Jun 06, 2017 - This drug approval was an important step forward in personalized medicine and marked another win for Merck's Keytruda.
Here's Why Loxo Oncology Soared as Much as 58.5% Today https://www.fool.com/investing/2017/06/05/heres-why-loxo-oncology-soared-as-much-as-585-toda.aspx?source=iedfolrf0000001 Jun 05, 2017 - The company announced interim data for three ongoing cancer trials.
3 Top Dividend Stocks in Diabetes Treatment https://www.fool.com/investing/2017/05/31/3-top-dividend-stocks-in-diabetes-treatment.aspx?source=iedfolrf0000001 May 31, 2017 - Looking for great dividend stocks of drugmakers with diabetes treatments? Check out AstraZeneca, Pfizer, and Sanofi.
Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum https://www.fool.com/investing/2017/08/09/celldex-therapeutics-inc-finishes-second-quarter-w.aspx?source=iedfolrf0000001 Aug 09, 2017 - The clinical-stage biotech awaits several critical clinical results in the coming months.

Pages: 12345678...83

<<<Page 3>